ReviewChronic kidney disease and diabetes
Introduction
Chronic kidney disease (CKD) affects a significant portion of the world population with a prevalence of 7.2% in adults over age 30 and dramatically increasing to 23.4–35.8% over age 65 [1]. Furthermore, population based studies in the United States reveals a CKD prevalence ranging from 1.4 to 43.3% [2]. The causes of CKD are various and include glomerular kidney disease, tubular and interstitial kidney disease, obstructive uropathy, pre renal and vascular disorders, diabetes and hypertension. Globally, diabetes is the most common cause of CKD.
There are multiple etiologies involved in the pathogenesis of diabetic CKD. The initial mechanism of damage involves adaptive hyperfiltration which leads to long term damage of functioning nephrons. Additional mechanisms of disease include advanced glycosylated end products (AGEs), vascular endothelial growth factor (VEGF), prorenin and the renin–angiotensin system, cytokines, nephrin expression and impaired podocyte signaling. Importantly, CKD is associated with an increased risk of cardiovascular disease, mortality and end stage renal disease. Most patients are likely to die than develop end stage renal disease. Treatments are limited but focus on treatment of associated causes including diabetes and hypertension, slowing progression of disease, treatment of complications and preparation for renal replacement therapy. This review examines the current literature on the epidemiology, pathogenesis, complications and treatment of CKD as well as possible areas of future disease intervention.
Diabetes mellitus is a disease that affects over 23.5 million American adults [3] and type 2 diabetes accounts for over 90% [4], [5]. Diabetes is the most common cause of CKD. The prevalence of some degree of CKD among adults with type 2 diabetes is 40% [3], [6], [7], [8], [9], [10], [11]. The 2009 annual report published by the United States Renal Data Systems, reports the prevalence rate of CKD in type 2 diabetes according to stage was 8.9% for stage I, 12.8% for stage II, 19.4% for stage III, and 2.7% for stages IV and V combined. The lifetime risk of developing CKD in type 1 diabetes is 25% [5], [12], [13], [14], [15], [16], [17].
The older population is especially affected by diabetic nephropathy. The incidence of end stage renal disease (ESRD) related to diabetes among the elderly markedly increased from the 1980s up until the late 1990s at which time there was slight decrease and leveling off to approximately 350–370/100,000 [4], [18], [19]. This more recent decline in CKD is likely due to earlier recognition and interventions.
In the 2010 Annual report published by the United States Renal Data Systems, the median age of incident ESRD population was 64.2 in 2008 which varied by race; the median age ranged from 59.2 among African Americans to 66.8 among whites. The rate of prevalence of CKD remains highest among the African American and Native American population, and lowest among the Caucasian and Asian population paralleling the rate of diabetes in these populations [20], [21]. The trend of increasing prevalence is expected to continue to grow as the elderly population continues to rise with increased life expectancy.
CKD in diabetes causes significant disability and contributes greatly to health care costs; annually approaching $23 billion with ESRD in the US [22]. McFarlane et al. [23] evaluated the risk of hospitalization, cardiovascular risk and death in patients with chronic kidney disease and reported that the adjusted risk of hospitalization increased as the estimated glomerular filtration rate (eGFR) decreased ranging from an increase of 14% with an estimated GFR of 45 to 59 ml/min/1.73 m2 to an increase of 315% with an estimated GFR of less than 15 ml/min/1.73 m2.
Section snippets
Diabetic nephropathy
CKD is defined as progressive, irreversible loss in kidney function. The National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (K/DOQI) defined CKD as lasting three or more months with either kidney damage defined by structural or functional abnormalities of the kidney with or without decreased eGFR, or a GFR of less than 60 ml/min/1.73 m2. These abnormalities include markers of kidney damage [1] such as albuminuria, abnormal urinary sediment (casts, epithelial cells),
Diet, weight reduction, exercise and smoking
Epidemiological studies reveal a relationship between lifestyle variables including diet, obesity, exercise and smoking and CKD. However, evidence of benefit is limited as there are few robust intervention studies [90], [91], [92], [93], [94], [95], [96], [97], [98].
The diet recommended is low protein and low carbohydrate diet. In the early stages of CKD, protein intake should not exceed 0.8–1.0 g kg/wt d, while in later stages of CKD protein should be limited to 0.8 g kg/wt d. Dietary restriction
Conclusions
The incidence of chronic kidney disease in diabetes continues to rise. This is especially true in the elderly population. CKD progresses from glomerular hyperfiltration to overt diabetic nephropathy. Microalbuminuria may not always progress to ESRD and conversely declining renal function may occur in the absence of declining GFR. Its pathogenesis is multifactorial including factors such as AGES, pro-renin, cytokines, nephrin expression, impaired podocyte signaling, changes in the
Contributors
All authors contributed equally to this manuscript.
Competing interests
There are no competing interests except M. Banerji. Mary Ann Banerji speakers Bureau – Merck, Amylin, Sanofi-Aventis, Boehringer-Ingleheim Advisory Boards; Data Monitoring Committees – Boehringer-Ingleheim, Novartis; BMS Research Grants – Merck, Boehringer-Ingleheim, Roche.
Provenance and peer review
Commissioned and externally peer reviewed.
References (149)
- et al.
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcome (KDIGO)
Kidney Int
(2005) - et al.
Prevalence of chronic kidney disease in population-based studies: systemic review
BMC Public Health
(2008) - et al.
Pathogenesis, and treatment of different stages of nephropathy in patients with Type 2 diabetes mellitus
Mayo Clin Proc
(2011) - et al.
Hypertension in diabetic nephropathy: epidemiology, mechanisms and management
Adv Chron Kidney Dis
(2011) - et al.
CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES)
Am J Kidney Dis
(2009) - et al.
Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States
Clin Ther
(2009) - et al.
Magnitude of end-stage renal disease in IDDM: a 35-year follow-up study
Kidney Int
(1996) - et al.
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)
Am J Kidney Dis
(2011) - et al.
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)
Kidney Int
(2003) - et al.
Renal function in black Americans with type II diabetes
J Diabet Complicat
(1989)
Renal disease and hypertension in non-insulin-dependent diabetes mellitus
Kidney Int
Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study
Kidney Int
Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy
Kidney Int
Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents
Kidney Int
Role of angiotensin II in diabetic nephropathy
Kidney Int
The renin–angiotensin–aldosterone system and the kidney: effects on kidney disease
Am J Med
Haemoglobin concentration and prognosis in new ccases of heart failure
Lancet
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
J Am Coll Cardiol
Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
Kidney Int
Adynamic bone in patients with chronic kidney disease
Kidney Int
Advanced glycation endproducts stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
Bone
Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium
Kidney Int
Body mass index and the risk of development of end-stage renal disease in a screened cohort
Kidney Int
Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension and renal function
Am J Kidney Dis
Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general population
Diabetes Med
Nephropathy in patients with Type 2 diabetes mellitus
N Engl J Med
Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes
CJSAN
Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration
Diabetes Med
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
Diabetes
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study
BMJ
Microalbuminuria and the risk for early progressive renal function decline in Type 1 diabetes
J Am Soc Nephrol
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients
Pediatr Endocrinol Rev
Diabetic nephropathy
Diabetol Metab Synd
CDC CKD surveillance team, association of CKD with disability in the United States
Am J Kidney Dis
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
N Engl J Med
A new equation to estimate glomerular filtration rate
Ann Int Med
National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
Ann Intern Med
Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring
Dan Med Bull
Diabetic nephropathy in type II diabetes: effect of metabolic control and blood pressure on its development and course
Dtsch Med Wochenschr
Main risk factors for nephropathy in Type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia
Arch Intern Med
The goal of blood pressure control for prevention of early diabetic microvascular complications
Curr Diabetes Rep
Intensive blood–glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia
Ann Saudi Med
Diabetes in Urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes
Diabetes Care
Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India
Postgrad Med J
Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
N Engl J Med
Cited by (72)
High-fat and carbohydrate diet caused chronic kidney damage by disrupting kidney function, caspase-3, oxidative stress and inflammation
2024, Prostaglandins and Other Lipid MediatorsGeospatial Modeling Methods in Epidemiological Kidney Research: An Overview and Practical Example
2024, Kidney International ReportsInhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy
2023, Molecular and Cellular EndocrinologyGenes, environment, and African ancestry in cardiometabolic disorders
2023, Trends in Endocrinology and MetabolismA preliminary study on health impacts of Mexican mercury mining workers in a context of precarious employment
2022, Journal of Trace Elements in Medicine and BiologyCitation Excerpt :Similarly, Global Burden Disease estimates, establish diabetes along with chronic renal injury as the second cause of death in Mexico until 2017 [89]. It should be noted that 17.6 % of mining workers have diabetes and the damage that manifests itself can be derived from that pathology [90]. However, about 42 % of workers already have some parameters altered to be considered prediabetic, which may act as risk factors in these people for presenting renal alterations [86].